Cargando…

Effects on postoperative nausea and vomiting of nefopam versus fentanyl following bimaxillary orthognathic surgery: a prospective double-blind randomized controlled trial

BACKGROUND: Postoperative nausea and vomiting (PONV) frequently occurs following bimaxillary orthognathic surgeries. Compared to opioids, Nefopam is associated with lower incidences of PONV, and does not induce gastrointestinal tract injury, coagulopathy, nephrotoxicity, or fracture healing dysfunct...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Eunhye, Karm, Myong-Hwan, So, Eunsun, Choi, Yoon Ji, Park, Sookyung, Oh, Yul, Yun, Hye Joo, Kim, Hyun Jeong, Seo, Kwang-Suk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Dental Society of Anesthsiology 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405349/
https://www.ncbi.nlm.nih.gov/pubmed/30859134
http://dx.doi.org/10.17245/jdapm.2019.19.1.55
_version_ 1783401055089852416
author Choi, Eunhye
Karm, Myong-Hwan
So, Eunsun
Choi, Yoon Ji
Park, Sookyung
Oh, Yul
Yun, Hye Joo
Kim, Hyun Jeong
Seo, Kwang-Suk
author_facet Choi, Eunhye
Karm, Myong-Hwan
So, Eunsun
Choi, Yoon Ji
Park, Sookyung
Oh, Yul
Yun, Hye Joo
Kim, Hyun Jeong
Seo, Kwang-Suk
author_sort Choi, Eunhye
collection PubMed
description BACKGROUND: Postoperative nausea and vomiting (PONV) frequently occurs following bimaxillary orthognathic surgeries. Compared to opioids, Nefopam is associated with lower incidences of PONV, and does not induce gastrointestinal tract injury, coagulopathy, nephrotoxicity, or fracture healing dysfunction, which are common side effects of Nonsteroidal anti-inflammatory drugs. We compared nefopam- and fentanyl-induced incidence of PONV in patients with access to patient-controlled analgesia (PCA) following bimaxillary orthognathic surgeries. METHODS: Patients undergoing bimaxillary orthognathic surgeries were randomly divided into nefopam and fentanyl groups. Nefopam 120 mg or fentanyl 700 µg was mixed with normal saline to a final volume of 120 mL. Patients were given access to nefopam or fentanyl via PCA. Postoperative pain intensity and PONV were measured at 30 minutes and 1 hour after surgery in the recovery room and at 8, 24, 48, and 72 hours after surgery in the ward. The frequency of bolus delivery was compared at each time point. RESULTS: Eighty-nine patients were enrolled in this study, with 48 in the nefopam (N) group and 41 in the fentanyl (F) group. PONV occurred in 13 patients (27.7%) in the N group and 7 patients (17.1%) in the F group at 8 hours post-surgery (P = 0.568), and there were no significant differences between the two groups at any of the time points. VAS scores were 4.4 ± 2.0 and 3.7 ± 1.9 in the N and F groups, respectively, at 8 hours after surgery (P = 0.122), and cumulative bolus delivery was 10.7 ± 13.7 and 8.6 ± 8.5, respectively (P = 0.408). There were no significant differences in pain or bolus delivery at any of the remaining time points. CONCLUSION: Patients who underwent bimaxillary orthognathic surgery and were given nefopam via PCA did not experience a lower rate of PONV compared to those that received fentanyl via PCA. Furthermore, nefopam and fentanyl did not provide significantly different postoperative pain control.
format Online
Article
Text
id pubmed-6405349
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher The Korean Dental Society of Anesthsiology
record_format MEDLINE/PubMed
spelling pubmed-64053492019-03-11 Effects on postoperative nausea and vomiting of nefopam versus fentanyl following bimaxillary orthognathic surgery: a prospective double-blind randomized controlled trial Choi, Eunhye Karm, Myong-Hwan So, Eunsun Choi, Yoon Ji Park, Sookyung Oh, Yul Yun, Hye Joo Kim, Hyun Jeong Seo, Kwang-Suk J Dent Anesth Pain Med Original Article BACKGROUND: Postoperative nausea and vomiting (PONV) frequently occurs following bimaxillary orthognathic surgeries. Compared to opioids, Nefopam is associated with lower incidences of PONV, and does not induce gastrointestinal tract injury, coagulopathy, nephrotoxicity, or fracture healing dysfunction, which are common side effects of Nonsteroidal anti-inflammatory drugs. We compared nefopam- and fentanyl-induced incidence of PONV in patients with access to patient-controlled analgesia (PCA) following bimaxillary orthognathic surgeries. METHODS: Patients undergoing bimaxillary orthognathic surgeries were randomly divided into nefopam and fentanyl groups. Nefopam 120 mg or fentanyl 700 µg was mixed with normal saline to a final volume of 120 mL. Patients were given access to nefopam or fentanyl via PCA. Postoperative pain intensity and PONV were measured at 30 minutes and 1 hour after surgery in the recovery room and at 8, 24, 48, and 72 hours after surgery in the ward. The frequency of bolus delivery was compared at each time point. RESULTS: Eighty-nine patients were enrolled in this study, with 48 in the nefopam (N) group and 41 in the fentanyl (F) group. PONV occurred in 13 patients (27.7%) in the N group and 7 patients (17.1%) in the F group at 8 hours post-surgery (P = 0.568), and there were no significant differences between the two groups at any of the time points. VAS scores were 4.4 ± 2.0 and 3.7 ± 1.9 in the N and F groups, respectively, at 8 hours after surgery (P = 0.122), and cumulative bolus delivery was 10.7 ± 13.7 and 8.6 ± 8.5, respectively (P = 0.408). There were no significant differences in pain or bolus delivery at any of the remaining time points. CONCLUSION: Patients who underwent bimaxillary orthognathic surgery and were given nefopam via PCA did not experience a lower rate of PONV compared to those that received fentanyl via PCA. Furthermore, nefopam and fentanyl did not provide significantly different postoperative pain control. The Korean Dental Society of Anesthsiology 2019-02 2019-02-28 /pmc/articles/PMC6405349/ /pubmed/30859134 http://dx.doi.org/10.17245/jdapm.2019.19.1.55 Text en Copyright © 2019 Journal of Dental Anesthesia and Pain Medicine http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Choi, Eunhye
Karm, Myong-Hwan
So, Eunsun
Choi, Yoon Ji
Park, Sookyung
Oh, Yul
Yun, Hye Joo
Kim, Hyun Jeong
Seo, Kwang-Suk
Effects on postoperative nausea and vomiting of nefopam versus fentanyl following bimaxillary orthognathic surgery: a prospective double-blind randomized controlled trial
title Effects on postoperative nausea and vomiting of nefopam versus fentanyl following bimaxillary orthognathic surgery: a prospective double-blind randomized controlled trial
title_full Effects on postoperative nausea and vomiting of nefopam versus fentanyl following bimaxillary orthognathic surgery: a prospective double-blind randomized controlled trial
title_fullStr Effects on postoperative nausea and vomiting of nefopam versus fentanyl following bimaxillary orthognathic surgery: a prospective double-blind randomized controlled trial
title_full_unstemmed Effects on postoperative nausea and vomiting of nefopam versus fentanyl following bimaxillary orthognathic surgery: a prospective double-blind randomized controlled trial
title_short Effects on postoperative nausea and vomiting of nefopam versus fentanyl following bimaxillary orthognathic surgery: a prospective double-blind randomized controlled trial
title_sort effects on postoperative nausea and vomiting of nefopam versus fentanyl following bimaxillary orthognathic surgery: a prospective double-blind randomized controlled trial
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405349/
https://www.ncbi.nlm.nih.gov/pubmed/30859134
http://dx.doi.org/10.17245/jdapm.2019.19.1.55
work_keys_str_mv AT choieunhye effectsonpostoperativenauseaandvomitingofnefopamversusfentanylfollowingbimaxillaryorthognathicsurgeryaprospectivedoubleblindrandomizedcontrolledtrial
AT karmmyonghwan effectsonpostoperativenauseaandvomitingofnefopamversusfentanylfollowingbimaxillaryorthognathicsurgeryaprospectivedoubleblindrandomizedcontrolledtrial
AT soeunsun effectsonpostoperativenauseaandvomitingofnefopamversusfentanylfollowingbimaxillaryorthognathicsurgeryaprospectivedoubleblindrandomizedcontrolledtrial
AT choiyoonji effectsonpostoperativenauseaandvomitingofnefopamversusfentanylfollowingbimaxillaryorthognathicsurgeryaprospectivedoubleblindrandomizedcontrolledtrial
AT parksookyung effectsonpostoperativenauseaandvomitingofnefopamversusfentanylfollowingbimaxillaryorthognathicsurgeryaprospectivedoubleblindrandomizedcontrolledtrial
AT ohyul effectsonpostoperativenauseaandvomitingofnefopamversusfentanylfollowingbimaxillaryorthognathicsurgeryaprospectivedoubleblindrandomizedcontrolledtrial
AT yunhyejoo effectsonpostoperativenauseaandvomitingofnefopamversusfentanylfollowingbimaxillaryorthognathicsurgeryaprospectivedoubleblindrandomizedcontrolledtrial
AT kimhyunjeong effectsonpostoperativenauseaandvomitingofnefopamversusfentanylfollowingbimaxillaryorthognathicsurgeryaprospectivedoubleblindrandomizedcontrolledtrial
AT seokwangsuk effectsonpostoperativenauseaandvomitingofnefopamversusfentanylfollowingbimaxillaryorthognathicsurgeryaprospectivedoubleblindrandomizedcontrolledtrial